These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27932887)

  • 1. Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients.
    Huang JY; Hsu CW; Yang CW; Hung CC; Huang WH
    Ther Clin Risk Manag; 2016; 12():1797-1803. PubMed ID: 27932887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Concentration of Indoxyl Sulfate in Peritoneal Dialysis Patients and Low-Flux Hemodialysis Patients.
    Xie T; Bao M; Zhang P; Jiao X; Zou J; Ding X; Cao X; Yu X
    Blood Purif; 2019; 48(2):183-190. PubMed ID: 31039561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival predictors in anuric patients on peritoneal dialysis: A prospective, multicenter, propensity score-matched cohort study.
    Park JY; Cho JH; Jang HM; Kim YS; Kang SW; Yang CW; Kim NH; Choi JY; Park SH; Kim CD; Kim YL
    PLoS One; 2018; 13(4):e0196294. PubMed ID: 29694445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
    Huang WH; Hung CC; Yang CW; Huang JY
    Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.
    Lee CT; Kuo CC; Chen YM; Hsu CY; Lee WC; Tsai YC; Ng HY; Kuo LC; Chiou TT; Yang YK; Cheng BC; Chen JB
    Perit Dial Int; 2010; 30(4):456-63. PubMed ID: 20338972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.
    Bataille S; Pelletier M; Sallée M; Berland Y; McKay N; Duval A; Gentile S; Mouelhi Y; Brunet P; Burtey S
    BMC Nephrol; 2017 Jul; 18(1):251. PubMed ID: 28747155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of survival in anuric peritoneal dialysis patients.
    Jansen MA; Termorshuizen F; Korevaar JC; Dekker FW; Boeschoten E; Krediet RT;
    Kidney Int; 2005 Sep; 68(3):1199-205. PubMed ID: 16105051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between Kt/V(urea) and nPNA in anuric peritoneal dialysis patients: a comparison with predialysis patients.
    Jansen MA; Korevaar JC; Dekker FW; Jager KJ; Boeschoten EW; Krediet RT;
    Perit Dial Int; 2001; 21(5):509-15. PubMed ID: 11757836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.
    Wang AY; Woo J; Wang M; Sea MM; Sanderson JE; Lui SF; Li PK
    Nephrol Dial Transplant; 2005 Feb; 20(2):396-403. PubMed ID: 15187196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium metabolism in continuous ambulatory peritoneal dialysis patients.
    Yu HL; Lu XH; Su CY; Tang W; Wang T
    Ren Fail; 2014 Jun; 36(5):748-54. PubMed ID: 24512377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Kt/V and creatinine clearance with outcomes in anuric peritoneal dialysis patients.
    Fried L; Hebah N; Finkelstein F; Piraino B
    Am J Kidney Dis; 2008 Dec; 52(6):1122-30. PubMed ID: 18617306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
    Shen JI; Saxena AB; Vangala S; Dhaliwal SK; Winkelmayer WC
    BMC Nephrol; 2017 Jun; 18(1):196. PubMed ID: 28623899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with angiotensin II inhibitors and residual renal function in peritoneal dialysis patients.
    Kolesnyk I; Noordzij M; Dekker FW; Boeschoten EW; Krediet RT
    Perit Dial Int; 2011; 31(1):53-9. PubMed ID: 20522672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients.
    Lin X; Lin A; Ni Z; Yao Q; Zhang W; Yan Y; Fang W; Gu A; Axelsson J; Qian J
    Nephrol Dial Transplant; 2010 Jul; 25(7):2322-7. PubMed ID: 20118483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal and optimal peritoneal Kt/V targets: results of an anuric peritoneal dialysis patient's survival analysis.
    Lo WK; Lui SL; Chan TM; Li FK; Lam MF; Tse KC; Tang SC; Choy CB; Lai KN
    Kidney Int; 2005 May; 67(5):2032-8. PubMed ID: 15840054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are peritoneal dialysis patients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of death.
    Szeto CC; Wong TY; Chow KM; Leung CB; Li PK
    Nephrol Dial Transplant; 2003 May; 18(5):977-82. PubMed ID: 12686674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
    Pilkey RM; Morton AR; Iliescu EA
    Adv Perit Dial; 2001; 17():153-7. PubMed ID: 11510266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Movilli E; Camerini C; Gaggia P; Zubani R; Cancarini G
    Am J Nephrol; 2018; 48(2):79-86. PubMed ID: 30071530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.